OPM
DEAD

Serial Number

98641117

Owner

Shanghai OPM Biosciences Co., Ltd.

Attorney

Shanshan Liang

Filing Date

Jul 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

OPM Trademark

Serial Number: 98641117

OPM is a trademark filed by Shanghai OPM Biosciences Co., Ltd. on July 10, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Shanghai OPM Biosciences Co., Ltd. (5 trademarks)

Building 28, 908 Ziping Road, Pudong
Shanghai, Shanghai 201321 , CN

Entity Type: 03

Trademark Details

Filing Date

July 10, 2024

Registration Date

Not Registered

Goods & Services

organotherapy preparations for medical use; biochemical pharmaceutical preparations for medical use; Medicinal serums; pharmaceutical chemical preparations, namely, for medical use; medical stem cells; medical chemical preparations for medical purposes; chemical reagents for medical or veterinary use; microbiological tissue cultures for medical or veterinary use; immunoassay reagents for medical use; biological preparations for medical use in cell cultures; biological tissue cultures for medical use; diagnostic preparations for medical use; Pharmaceutical active ingredients for use in the manufacture of drugs.

chemical research services; gene screening in the nature of genetic testing for scientific research purposes; information technology consulting relating to installation, maintenance and repair of computer software; scientific laboratory services; scientific research and development; scientific research in the nature of conducting clinical trials for others; biological research; research and development of new products for others; drug evaluation in the nature of pharmaceutical product evaluation; pharmaceutical research

arrange and organize conferences, namely, arranging and conducting of conferences in the field of biotechnology, pharmaceutical sciences, and biopharmaceutical development; arrange and organize training sessions, namely, arranging and conducting of training seminars in the field of biotechnology research, pharmaceutical manufacturing and cell culture technology; arrange and organize academic seminars, namely, arranging and conducting of educational seminars in the field of biopharmaceutical research, drug development, and pharmaceutical sciences; arrange and organize expert discussions, namely, arranging and conducting of symposiums in the field of biopharmaceutical development, biologics manufacturing, and pharmaceutical innovation; arrange and organize specialized workshops, namely, arranging and conducting of specialized workshops in the field of cell culture media technology, bioprocess development, and biotechnology applications

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 9, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 9, 2026 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 22, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 22, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2025 NWOS
NEW APPLICATION ENTERED
Jul 10, 2024 NWAP